Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation

Detalhes bibliográficos
Autor(a) principal: Simões, André
Data de Publicação: 2015
Outros Autores: Pereira, D. M., Gomes, S. E., Brito, H., Carvalho, Tânia, French, A., Castro, Rui E., Steer, C. J., Thibodeau, S. N., Rodrigues, Cecília M. P., Borralho, P. M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/53175
Resumo: © 2015 Macmillan Publishers Limited All rights reserved. Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
id RCAP_dd650f476db204bb51cecd0a729b90bf
oai_identifier_str oai:repositorio.ul.pt:10451/53175
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation© 2015 Macmillan Publishers Limited All rights reserved. Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0This study was designed to evaluate MEK5 and ERK5 expression in colon cancer progression and to ascertain the relevance of MEK5/ERK5 signalling in colon cancer. Expression of MEK5 and ERK5 was evaluated in 323 human colon cancer samples. To evaluate the role of MEK5/ERK5 signalling in colon cancer, we developed a stable cell line model with differential MEK5/ERK5 activation. Impact of differential MEK5/ERK5 signalling was evaluated on cell cycle progression by flow cytometry and cell migration was evaluated by wound healing and transwell migration assays. Finally, we used an orthotopic xenograft mouse model of colon cancer to assess tumour growth and progression. Our results demonstrated that MEK5 and ERK5 are overexpressed in human adenomas (P<0.01) and adenocarcinomas (P<0.05), where increased ERK5 expression correlated with the acquisition of more invasive and metastatic potential (P<0.05). Interestingly, we observed a significant correlation between ERK5 expression and NF-κB activation in human adenocarcinomas (P<0.001). We also showed that ERK5 overactivation significantly accelerated cell cycle progression (P<0.05) and increased cell migration (P<0.01). Furthermore, cells with overactivated ERK5 displayed increased NF-κB nuclear translocation and transcriptional activity (P<0.05), together with increased expression of the mesenchymal marker vimentin (P<0.05). We further demonstrated that increased NF-κB activation was associated with increased IκB phosphorylation and degradation (P<0.05). Finally, in the mouse model, lymph node metastasis was exclusively seen in orthotopically implanted tumours with overactivated MEK5/ERK5, and not in tumours with inhibited MEK5/ERK5. Our results suggested that MEK5/ERK5/NF-κB signalling pathway is important for tumour onset, progression and metastasis, possibly representing a novel relevant therapeutic target in colon cancer treatment.This study was supported by Fundação para a Ciência e Tecnologia (HMSP-ICT/0018/2011, SFRH/BD/96517/2013, SFRH/BD/88619/2012 and SFRH/BD/79356/2011).Springer NatureRepositório da Universidade de LisboaSimões, AndréPereira, D. M.Gomes, S. E.Brito, H.Carvalho, TâniaFrench, A.Castro, Rui E.Steer, C. J.Thibodeau, S. N.Rodrigues, Cecília M. P.Borralho, P. M.2022-05-25T15:28:04Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/53175engCell Death Dis. 2015 Apr 9;6(4):e171810.1038/cddis.2015.832041-4889info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:58:50Zoai:repositorio.ul.pt:10451/53175Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:04:08.664241Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
title Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
spellingShingle Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
Simões, André
title_short Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
title_full Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
title_fullStr Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
title_full_unstemmed Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
title_sort Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
author Simões, André
author_facet Simões, André
Pereira, D. M.
Gomes, S. E.
Brito, H.
Carvalho, Tânia
French, A.
Castro, Rui E.
Steer, C. J.
Thibodeau, S. N.
Rodrigues, Cecília M. P.
Borralho, P. M.
author_role author
author2 Pereira, D. M.
Gomes, S. E.
Brito, H.
Carvalho, Tânia
French, A.
Castro, Rui E.
Steer, C. J.
Thibodeau, S. N.
Rodrigues, Cecília M. P.
Borralho, P. M.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Simões, André
Pereira, D. M.
Gomes, S. E.
Brito, H.
Carvalho, Tânia
French, A.
Castro, Rui E.
Steer, C. J.
Thibodeau, S. N.
Rodrigues, Cecília M. P.
Borralho, P. M.
description © 2015 Macmillan Publishers Limited All rights reserved. Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
2022-05-25T15:28:04Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/53175
url http://hdl.handle.net/10451/53175
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Cell Death Dis. 2015 Apr 9;6(4):e1718
10.1038/cddis.2015.83
2041-4889
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134592194576384